Journal
Neuro-Oncology Advances
Publication Date
1-1-2023
Volume
5
Issue
1
First Page
vdad116
Document Type
Open Access Publication
DOI
10.1093/noajnl/vdad116
Rights and Permissions
Tracy T Batchelor, Minhee Won, Arnab Chakravarti, Costas G Hadjipanayis, Wenyin Shi, Lynn S Ashby, Volker W Stieber, H Ian Robins, Heidi J Gray, Alfredo Voloschin, John B Fiveash, Clifford G Robinson, UshaSree Chamarthy, Young Kwok, Terrence P Cescon, Anand K Sharma, Rekha Chaudhary, Mei-Yin Polley, Minesh P Mehta, NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma, Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad116, https://doi.org/10.1093/noajnl/vdad116. https://academic.oup.com/noa/article/5/1/vdad116/7306865?login=true. © The Author(s) 2023. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Batchelor, Tracy T; Robinson, Clifford G; and et al., "NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma." Neuro-Oncology Advances. 5, 1. vdad116 (2023).
https://digitalcommons.wustl.edu/oa_4/2801
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
